MALVERN, Pa. (AP) — MALVERN, Pa. (AP) — Ocugen, Inc. (OCGN) on Friday reported a loss of $14.7 million in its second quarter.

On a per-share basis, the Malvern, Pennsylvania-based company said it had a loss of 5 cents.

The biotech knee implant developer posted revenue of $1.4 million in the period.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCGN at https://www.zacks.com/ap/OCGN

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights.